Drug Formularies: Purposes, Intent, and Challenges
January 14, 2025
A plan’s formulary (or drug list) is a list of prescription drugs approved for coverage by plan sponsors such as public and private employers, unions,
PCMA Urges CMS to Stabilize the Medicare Part D Plan Marketplace
November 7, 2024
By Tim Dube, SVP, Policy and Regulatory Insights, Pharmaceutical Care Management Association Last week, PCMA offered recommendations to the Centers for Medicare and Medicaid Services
CMS Should Protect the Financial Health of Pharmacies When Implementing the IRA
November 4, 2024
By Tim Dube, SVP, Policy and Regulatory Insights, Pharmaceutical Care Management Association If the community pharmacy lobby is right, America’s Medicare beneficiaries may not be
Amid IRA Implementation, PBMs Continue to Deliver Value and Savings for Medicare Beneficiaries
September 18, 2024
By Tim Dube, SVP, Policy and Regulatory Insights It’s been two years since President Biden signed the Inflation Reduction Act (IRA) into law, whose several
